• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
COH
Click for more information
1.67% $293.02

COCHLEAR LIMITED - Announcements

Market Cap $18.63B  ! watchlist Created with Sketch. Add to my watchlist

Cochlear Limited is an Australia-based company, which provides implantable hearing... Cochlear Limited is an Australia-based company, which provides implantable hearing solutions and sound processors. The Company is engaged in development, manufacture and commercialization of implantable hearing solutions. Its segments include Cochlear implants, Services (sound processor upgrades and other) and Acoustics. The Company’s products and services portfolio include Cochlear implant portfolio, Acoustic solutions portfolio, and Recipient support tools. Its Cochlear Connected Care solutions include Cochlear Nucleus SmartNav System, Cochlear Custom Sound Pro Fitting Software, Cochlear Link, Cochlear Remote Assist, and Cochlear Remote Check solution for cochlear implants. Its Cochlear implant portfolio include Cochlear Nucleus System. Its Acoustic solutions portfolio include Cochlear Osia System, and Cochlear Baha System. Its Recipient support tools include Cochlear Nucleus, Baha and Osia Smart Apps and Cochlear CoPilot App.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
COH Voting Form18/09/15
COH Invitation letter from Chairman - AGM18/09/15
COH Notice of Annual General Meeting18/09/15
COH Appendix 3Y - Chris Smith15/09/15
COH Appendix 3B08/09/15
COH Change in substantial holding07/09/15
COH Appendix 3X - Chris Smith04/09/15
COH Appendix 3Z - Chris Roberts01/09/15
COH Appendix 3B01/09/15
COH Appendix 3B31/08/15
COH CEO HANDOVER EFFECTIVE AND RELATED BOARD CHANGES31/08/15
COH Appendix 3Y - Chris Roberts27/08/15
COH Appendix 3B25/08/15
COH Appendix 3Y - Glen Boreham24/08/15
COH Appendix 3Y - Dr Chris Roberts21/08/15
COH Appendix 3Y - Rick Holliday-Smith17/08/15
COH Dividend/Distribution - COH12/08/15
COH COH Full Year Results Analyst Presentation 11.08.201511/08/15
COH Full Year Statutory Accounts and Annual ReportPRICE SENSITIVE11/08/15
COH Updated Trading Policy30/06/15
COH COH Chris Smith Announced as Incoming CEO of CochlearPRICE SENSITIVE26/05/15
COH Judgment in United States Patent Infringement LawsuitPRICE SENSITIVE21/04/15
COH DECISION IN US PATENT INFRINGEMENT CASEPRICE SENSITIVE01/04/15
COH Half Year Report 201526/03/15
COH Ceasing to be a substantial holder13/03/15
COH Appendix 3Y - Alison Deans10/03/15
COH Appendix 3Y - Chris Roberts06/03/15
COH Appendix 3Y - Dr. Chris Roberts25/02/15
COH Appendix 3Y - Dr. Chris Roberts19/02/15
COH COH Half Year Results Analyst Presentation10/02/15
COH COH Half Year Results Media Release 10.02.201510/02/15
COH Half Year Report & AccountsPRICE SENSITIVE10/02/15
COH Change in substantial holding21/01/15
COH Appendix 3X - Glen Boreham10/12/14
COH Appendix 3X - Alison Deans10/12/14
COH Director Appointment09/12/14
COH Director Appointment09/12/14
COH Ceasing to be a substantial holder17/11/14
COH Appendix 3Y - Dr Chris Roberts14/11/14
COH Appendix 3Y - Dr. Chris Roberts07/11/14
COH Becoming a substantial holder05/11/14
COH Ceasing to be a substantial holder24/10/14
COH Appendix 3Y - Dr Chris Roberts21/10/14
COH Appendix 3B21/10/14
COH Appendix 3B - Cochlear Employee Share Plan20/10/14
COH Appendix 3Z - Paul Bell17/10/14
COH COH 2014 AGM - Results of Meeting14/10/14
COH 14/10/14 Cochlear AGM Presentation to Shareholders14/10/14
COH 14/10/14 Chairmans AGM Address to Shareholdres14/10/14
COH Change in substantial holding02/10/14
COH Appendix 3Y - Dr Chris Roberts16/09/14
COH Appendix 3B12/09/14
COH Voting Form12/09/14
COH Notice of Annual General Meeting12/09/14
COH Annual Report to Shareholders - Financial12/09/14
COH Annual Report to Shareholders - Editorial12/09/14
COH Change of Director's Interest Notice - Dr. Chris Roberts10/09/14
COH Change of Director's Interest Notice - Yasmin Allen27/08/14
COH Change of Director's Interest Notice - Dr. Chris Roberts26/08/14
COH Ceasing to be a substantial holder26/08/14
COH Change of Director's Interest Notice - Dr. Chris Roberts22/08/14
COH Change of Director's Interest Notice - Dr. Chris Roberts14/08/14
COH COH Full Year Results Analyst Presentation 05.08.201405/08/14
COH COH Full Year Results Media Release 05.08.14PRICE SENSITIVE05/08/14
COH Preliminary Final Report and Full Year Statutory AccountsPRICE SENSITIVE05/08/14
COH Change in substantial holding14/07/14
COHCOCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROPPRICE SENSITIVE02/06/14
COHCeasing to be a substantial holder30/05/14
COHBecoming a substantial holder29/05/14
COHChange in substantial holding26/05/14
COHBecoming a substantial holder08/05/14
COHBecoming a substantial holder08/05/14
COHCeasing to be a substantial holder08/05/14
COHHalf Year Report 201427/03/14
COHFDA approves Cochlear Nucleus Hybrid for sale in USAPRICE SENSITIVE21/03/14
COHCeasing to be a substantial holder10/03/14
COHBecoming a substantial holder07/03/14
COHChange of Director's Interest Notice - Dr Chris Roberts06/03/14
COHChange of Director's Interest Notice - Dr Chris Roberts25/02/14
COHChange of Director's Interest Notice - Donal O'Dwyer19/02/14
COHChange of Director's Interest Notice - Dr Chris Roberts19/02/14
COHCeasing to be a substantial holder14/02/14
COHBecoming a substantial holder13/02/14
COHChange of Director's Interest Notice - Dr Chris Roberts12/02/14
COHCOH Half Year Results Analyst Presentaton 11.02.1411/02/14
COHCOH Half Year Results Media Release 11.02.1411/02/14
COHHalf Year Report & AccountsPRICE SENSITIVE11/02/14
COHCOH Jury Trial Verdict on USA Patent Infringement CasePRICE SENSITIVE24/01/14
COHCeasing to be a substantial holder13/01/14
COHBecoming a substantial holder08/01/14
COHCeasing to be a substantial holder13/12/13
COHBecoming a substantial holder12/12/13
COHCeasing to be a substantial holder12/12/13
COHCeasing to be a substantial holder11/12/13
COHBecoming a substantial holder26/11/13
COHCeasing to be a substantial holder20/11/13
COHChange of Director's Interest Notice - Dr. Chris Roberts18/11/13
COHChange of Director's Interest Notice - Dr. Chris Roberts13/11/13
COHBecoming a substantial holder12/11/13
COHHybrid Hearing Device UpdatePRICE SENSITIVE11/11/13
COH Voting Form
18/09/15
COH Invitation letter from Chairman - AGM
18/09/15
COH Notice of Annual General Meeting
18/09/15
COH Appendix 3Y - Chris Smith
15/09/15
COH Appendix 3B
08/09/15
COH Change in substantial holding
07/09/15
COH Appendix 3X - Chris Smith
04/09/15
COH Appendix 3Z - Chris Roberts
01/09/15
COH Appendix 3B
01/09/15
COH Appendix 3B
31/08/15
COH CEO HANDOVER EFFECTIVE AND RELATED BOARD CHANGES
31/08/15
COH Appendix 3Y - Chris Roberts
27/08/15
COH Appendix 3B
25/08/15
COH Appendix 3Y - Glen Boreham
24/08/15
COH Appendix 3Y - Dr Chris Roberts
21/08/15
COH Appendix 3Y - Rick Holliday-Smith
17/08/15
COH Dividend/Distribution - COH
12/08/15
COH COH Full Year Results Analyst Presentation 11.08.2015
11/08/15
COH Full Year Statutory Accounts and Annual Report
11/08/15PRICE SENSITIVE
COH Updated Trading Policy
30/06/15
COH COH Chris Smith Announced as Incoming CEO of Cochlear
26/05/15PRICE SENSITIVE
COH Judgment in United States Patent Infringement Lawsuit
21/04/15PRICE SENSITIVE
COH DECISION IN US PATENT INFRINGEMENT CASE
01/04/15PRICE SENSITIVE
COH Half Year Report 2015
26/03/15
COH Ceasing to be a substantial holder
13/03/15
COH Appendix 3Y - Alison Deans
10/03/15
COH Appendix 3Y - Chris Roberts
06/03/15
COH Appendix 3Y - Dr. Chris Roberts
25/02/15
COH Appendix 3Y - Dr. Chris Roberts
19/02/15
COH COH Half Year Results Analyst Presentation
10/02/15
COH COH Half Year Results Media Release 10.02.2015
10/02/15
COH Half Year Report & Accounts
10/02/15PRICE SENSITIVE
COH Change in substantial holding
21/01/15
COH Appendix 3X - Glen Boreham
10/12/14
COH Appendix 3X - Alison Deans
10/12/14
COH Director Appointment
09/12/14
COH Director Appointment
09/12/14
COH Ceasing to be a substantial holder
17/11/14
COH Appendix 3Y - Dr Chris Roberts
14/11/14
COH Appendix 3Y - Dr. Chris Roberts
07/11/14
COH Becoming a substantial holder
05/11/14
COH Ceasing to be a substantial holder
24/10/14
COH Appendix 3Y - Dr Chris Roberts
21/10/14
COH Appendix 3B
21/10/14
COH Appendix 3B - Cochlear Employee Share Plan
20/10/14
COH Appendix 3Z - Paul Bell
17/10/14
COH COH 2014 AGM - Results of Meeting
14/10/14
COH 14/10/14 Cochlear AGM Presentation to Shareholders
14/10/14
COH 14/10/14 Chairmans AGM Address to Shareholdres
14/10/14
COH Change in substantial holding
02/10/14
COH Appendix 3Y - Dr Chris Roberts
16/09/14
COH Appendix 3B
12/09/14
COH Voting Form
12/09/14
COH Notice of Annual General Meeting
12/09/14
COH Annual Report to Shareholders - Financial
12/09/14
COH Annual Report to Shareholders - Editorial
12/09/14
COH Change of Director's Interest Notice - Dr. Chris Roberts
10/09/14
COH Change of Director's Interest Notice - Yasmin Allen
27/08/14
COH Change of Director's Interest Notice - Dr. Chris Roberts
26/08/14
COH Ceasing to be a substantial holder
26/08/14
COH Change of Director's Interest Notice - Dr. Chris Roberts
22/08/14
COH Change of Director's Interest Notice - Dr. Chris Roberts
14/08/14
COH COH Full Year Results Analyst Presentation 05.08.2014
05/08/14
COH COH Full Year Results Media Release 05.08.14
05/08/14PRICE SENSITIVE
COH Preliminary Final Report and Full Year Statutory Accounts
05/08/14PRICE SENSITIVE
COH Change in substantial holding
14/07/14
COHCOCHLEAR TO LAUNCH NUCLEUS PROFILE IMPLANT SERIES IN EUROP
02/06/14PRICE SENSITIVE
COHCeasing to be a substantial holder
30/05/14
COHBecoming a substantial holder
29/05/14
COHChange in substantial holding
26/05/14
COHBecoming a substantial holder
08/05/14
COHBecoming a substantial holder
08/05/14
COHCeasing to be a substantial holder
08/05/14
COHHalf Year Report 2014
27/03/14
COHFDA approves Cochlear Nucleus Hybrid for sale in USA
21/03/14PRICE SENSITIVE
COHCeasing to be a substantial holder
10/03/14
COHBecoming a substantial holder
07/03/14
COHChange of Director's Interest Notice - Dr Chris Roberts
06/03/14
COHChange of Director's Interest Notice - Dr Chris Roberts
25/02/14
COHChange of Director's Interest Notice - Donal O'Dwyer
19/02/14
COHChange of Director's Interest Notice - Dr Chris Roberts
19/02/14
COHCeasing to be a substantial holder
14/02/14
COHBecoming a substantial holder
13/02/14
COHChange of Director's Interest Notice - Dr Chris Roberts
12/02/14
COHCOH Half Year Results Analyst Presentaton 11.02.14
11/02/14
COHCOH Half Year Results Media Release 11.02.14
11/02/14
COHHalf Year Report & Accounts
11/02/14PRICE SENSITIVE
COHCOH Jury Trial Verdict on USA Patent Infringement Case
24/01/14PRICE SENSITIVE
COHCeasing to be a substantial holder
13/01/14
COHBecoming a substantial holder
08/01/14
COHCeasing to be a substantial holder
13/12/13
COHBecoming a substantial holder
12/12/13
COHCeasing to be a substantial holder
12/12/13
COHCeasing to be a substantial holder
11/12/13
COHBecoming a substantial holder
26/11/13
COHCeasing to be a substantial holder
20/11/13
COHChange of Director's Interest Notice - Dr. Chris Roberts
18/11/13
COHChange of Director's Interest Notice - Dr. Chris Roberts
13/11/13
COHBecoming a substantial holder
12/11/13
COHHybrid Hearing Device Update
11/11/13PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
$293.02 		Change
-4.980(1.67%) 		Mkt cap ! $18.63B
Open High Low Value Volume
$300.33 $302.50 $290.30 $40.27M 136.9K

Buyers (Bids)

No. Vol. Price($)
1 83 $292.79
 

Sellers (Offers)

Price($) Vol. No.
$293.09 629 2
View Market Depth
Last trade - 16.10pm 21/11/2024 (20 minute delay) ?
Last
$292.65 		  Change
-4.980 ( 1.75 %)
Open High Low Volume
$301.49 $301.49 $290.32 25631
Last updated 15.59pm 21/11/2024 ?
COH (ASX) Chart

Top Stories

Alcidion inks deal with Vic health provider Peninsula for use of Miya Precision tech

Alcidion Group Ltd has signed a contract worth $3.7M to enable use of its Miya Precision platform by users of Peninsula Health entities
To make modern missiles, you need 3D Printing. And in that gold rush, Amaero is selling shovels Put simply: if 3D Printing is a gold rush, Amaero is selling shovels. Or maybe it's more like sneakers in an arms race.
MinRes's Ellison knows he screwed up – for that reason, hunt for new Chair to be sped up Who the MinRes Board has decided to move on faster may or may not be amusing, depending on how much you've lost.
Bigtincan's Board backs Investcorp offer: Why a NASDAQ listing could be game-changing Bigtincan Holdings has fielded an offer from Investcorp. But if you think it's underwhelming – consider Wall Street volumes.
Pan Asia rebranding to 'clear confusion' after bagging $35M for Chile projects Pan Asia Metals has scored $35 million from a New York private equity firm at the same time as the company's big rebrand push begins.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.